08.10 09:54 | dpa-AFX: *UBS RAISES HALEON PRICE TARGET TO 445 (410) PENCE - 'BUY' |
08.10 08:23 | dpa-AFX: *DEUTSCHE BANK RESEARCH HEBT ZIEL FÜR HALEON AUF 375 (340) PENCE - 'HOLD' |
08.10 08:23 | dpa-AFX: *DEUTSCHE BANK RESEARCH RAISES HALEON PRICE TARGET TO 375 (340) PENCE - 'HOLD' |
08.10 06:36 | dpa-AFX: *BARCLAYS CUTS HALEON PRICE TARGET TO 406 (407) PENCE - 'OVERWEIGHT' |
01.10 15:03 | dpa-AFX: *HALEON APPOINTS CHRISTINE JAKOVCICAS AS GENERAL MANAGER, HALEON CANADA |
01.10 08:26 | dpa-AFX: Pfizer's Total Interest In Haleon To Reduce From Approx. 22.6% To Approx. 15.0% |
27.09 12:44 | dpa-AFX: Haleon To Buy Addl. 33% Stake In China JV, Totaling 88% |
27.09 12:19 | dpa-AFX: *HALEON TO INCREASE STAKE IN CHINA JV TO 88% |
13.09 05:46 | dpa-AFX: *JEFFERIES RAISES HALEON PRICE TARGET TO 450 (410) PENCE - 'BUY' |
10.09 13:44 | dpa-AFX: *BOFA RAISES HALEON PRICE TARGET TO 440 (400) PENCE - 'BUY' |
03.09 14:57 | dpa-AFX: Haleon Announces Launch Of Eroxon In The U.S. For Preorder Without Prescription |
03.09 14:19 | dpa-AFX: *HALEON ANNOUNCES LAUNCH OF EROXON AVAILABLE FOR U.S. PREORDER WITHOUT PRESCRIPTION |
06.08 10:14 | dpa-AFX: *GOLDMAN SENKT HALEON AUF 'NEUTRAL' (BUY) - ZIEL 380 (360) PENCE |
06.08 10:14 | dpa-AFX: *GOLDMAN CUTS HALEON TO 'NEUTRAL' (BUY) - PRICE TARGET 380 (360) PENCE |
06.08 08:45 | dpa-AFX: *BERENBERG RAISES HALEON PRICE TARGET TO 447 (410) PENCE - 'BUY' |
02.08 06:49 | dpa-AFX: *BARCLAYS RAISES HALEON PRICE TARGET TO 407 (386) PENCE - 'OVERWEIGHT' |
02.08 05:51 | dpa-AFX: *JEFFERIES RAISES HALEON PRICE TARGET TO 410 (385) PENCE - 'BUY' |
01.08 18:29 | dpa-AFX: *JPMORGAN RAISES HALEON PRICE TARGET TO 300 (290) PENCE - 'UNDERWEIGHT' |
01.08 09:13 | dpa-AFX: Haleon H1 Pretax Profit Rises; Organic Revenue Growth At 3.5% |
01.08 08:20 | dpa-AFX: *HALEON H1 ADJ. EPS 9.0P VS. 8.5P LAST YEAR |
|